ABSTRACT: To evaluate the effects of intraarticular injections of autologous platelet-rich plasma (PRP) or bone marrow concentrate (BMC) on osteoarthritis (OA), 24 adult goats were equally divided into control (Ctrl), saline (NS), PRP, and BMC groups, and OA was induced by surgery in NS, PRP, and BMC groups. Autologous PRP and BMC were obtained from whole blood and bone marrow aspirates, respectively. The data revealed, platelets were increased in BMC by 1.8-fold, monocytes by 5.6-fold, TGF-b1 by 7.7-fold, and IGF-1 by 3.6-fold (p < 0.05), and platelets were increased in PRP by 2.9-fold, and TGF-b1 by 3.3-fold (p < 0.05). From the sixth week post-operation, saline, PRP, and BMC were administered by intraarticular injection once every 4 weeks, three consecutive times. After the animals were sacrificed, inflammatory cytokines in the synovial fluid was measured, and bone and cartilage degeneration progression was observed by macroscopy, histology, and immunohistochemistry. Compared with the NS group, the level of inflammatory cytokines was reduced in the PRP and BMC groups (p < 0.05). Histologically, delayed cartilage degeneration and higher levels of extracellular matrix (ECM) were observed in both PRP and BMC treated groups (p < 0.05). Furthermore, the BMC group showed greater cartilage protection and less ECM loss than the PRP group (p < 0.05). In summary, this study showed that intraarticular injection of autologous PRP and BMC has therapeutic efficacy in a goat osteoarthritis model, with the greater benefit in terms of cartilage protection being observed in the BMC-treated group than PRP. ß
Osteoarthritis (OA) is a progressive degenerative disorder in adults. Currently, conservative treatments have not been able to effectively modify or prevent the pathological degeneration from the final arthroplasty. 1 Recently, in the field of regenerative medicine, autologous biomaterials have been investigated as novel treatments for OA, with the aim to promote chondral repair and modify the disease progression. 2 Platelet-rich plasma (PRP) contains a high concentration of growth factors, including transforming growth factor-b (TGF-b), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF). Since the 1990s, PRP has been widely used in tissue lesions and degenerative disorders. [3] [4] [5] [6] Recent clinical studies have demonstrated that PRP administered by intraarticular injection can provide symptomatic relief and result in functional improvement in patients with mild to moderate knee OA. 7, 8 Mesenchymal stem cells (MSCs), which have potential anti-inflammatory, multi-differentiative, and secretory effects, have also been extensively studied in relation to chondral repair and degenerative arthritis. 9, 10 However, the complicated nature of in vitro MSC culture is associated with increased operational difficulty, contamination risk, and treatment cost, thus restricting their clinical application. 11 Recently, a technique for centrifuging bone marrow to generate bone marrow concentrate (BMC) has been developed. BMC contains high numbers of bone marrow mesenchymal stem cells (BMSCs), hematopoietic stem cells (HSCs), and platelets, and is therefore thought to combine the advantages of PRP and MSCs. 12, 13 Clinically, BMC has been used in the treatment of focal chondral and osteochondral defects, resulting in a functional improvement and the potential to recreate hyaline-like cartilage. 14, 15 In addition, several reports have demonstrated the benefit of BMC in facilitating the regeneration of articular cartilage in patients with knee OA. 16, 17 However, because previous reports lacked comparable intervention and utilized additional products, the direct effect of BMC on OA remains controversial. 18 The aim of this study was to evaluate the effects of PRP and BMC on degenerative arthritis and to compare the efficacy on cartilage protection between the two autologous biomaterials in an animal experiment.
MATERIALS AND METHODS
Experiment Design and Surgical Procedure Twenty-four male Boer goats (Qinglong Mountain Experimental Animal Center, Nanjing, China) weighing 40-50 kg and aged 12-18 months, were used in this study. Animals were randomly divided into four groups, with six goats in each group: control (Ctrl), saline (NS), PRP, and BMC groups. No differences were observed between the groups with respect to age and weight. The study was approved by the Nanjing Medical University Animal Ethical Committee (NJMU/IACUC 2016011801).
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The Ctrl group received no surgery or BMC injection. As in previous studies, OA was induced by complete anterior cruciate ligament transection and medial meniscectomy under general anesthesia and aseptic conditions, in the right knee joints. 10, 19 Post-operatively, all animals received antibiotics by intramuscular injection to prevent infection and were allowed to be fully weight bearing and to have unrestricted movement. Six weeks after the surgery, the goats were administered intra-articular injections of NS, PRP, or BMC in the right knees every 4 weeks, on three consecutive occasions. Six weeks after the last injection, all animals were pharmacologically euthanized. Synovial fluid was collected and macroscopic, histological, and immunohistochemical analyses were performed.
PRP Preparation
Fifty milliliters of whole blood (WB) was drawn from the auricular vein under general anesthesia and anticoagulated with 10 ml acid citrate dextrose (ACD, Nigale, Chengdu, China). PRP was produced by following a twostep centrifugation procedure (PRP Preparation Kits, WEGO, Weihai, China) under sterile conditions and at room temperature. The first step involved centrifugation at 350g for 10 mins, following which the upper plasma layer and middle buffy coat were collected and subjected to a second centrifugation at 450g for 15 mins to obtain 5 ml PRP. One milliliter of PRP and WB were used to obtain platelet and monocyte counts with an automatic hematology analyzer (Sysmex xe-2100, Sysmex Corporation, Kobe, Japan). The remaining 4 ml was divided into 2 units. One unit was injected intra-articularly into the right knee within 1 h of activation with CaCl 2 , as previously reported. 10 The levels of TGF-b1 and IGF-1 in another unit of PRP and in WB plasma were analyzed using ELISA kits (Cusabio, Wuhan, China).
BMC Preparation
In a similar manner to the preparation of PRP, 50 ml bone marrow (BM) was aspirated from both iliac crests and a twostep centrifugation procedure was used to produce 5 ml BMC. Cytological counts and levels of growth factors were ascertained using the same methods as described for PRP.
Synovial Fluid Analysis
Six weeks after the last injection, all goats were sacrificed by administering an intravenous injection of pentobarbital sodium (MERK, Darmstadt, Germany), and synovial fluid was subsequently collected from the right knee joints. Concentrations of interleukin-1b (IL-1b), interleukin-6 (IL-6), prostaglandin E2 (PGE2), and tumor necrosis factor-a (TNF-a) were measured using ELISA kits (Cusabio).
Gross Morphological Examination
Immediately after the animals were killed, the condyles of the femur and proximal tibial plateaus were carefully removed. Gross articular damage and osteophyte development were assessed in the medial and lateral areas of femoral condyles and tibial plateaus according to the OARSI macroscopic scoring method, 20 by two independent observers, and the overall score was then obtained. All of the samples were kept moist with saline throughout the examinations and photography sessions.
Histological Examination and Immunohistochemical Staining
After gross analysis and digital photography, 5-mm thick osteochondral slabs covering the sagittal width of the medial femoral condyles were cut using a sharp osteotome, fixed in 10% (v/v) neutral buffered formalin for 48 h, and decalcified according the previous report. 10 After paraffin embedding, 5-mm sections were cut and stained with haematoxylin and eosin (H&E) to evaluate the cellular architecture. Safranin O-Fast Green was used to detect cartilage extracellular matrix (ECM). Immunohistochemical staining was performed to assess the distribution of collagen 2 (COL-2) in the degenerative cartilage. Briefly, slides were incubated in primary antibody solution (ab34712, 1:100; Abcam, Cambridge, MA) followed by secondary antibody and substrate-chromogen solution, according to the manufacturer's instructions. Two observers blinded to the treatment carried out the histological examinations, by microscopy (Nikon Eclipse TI-SR, Nikon Corporation, Sendai, Japan), and employed a modified Mankin system for scoring the sections. 20 
Statistical Analysis
Results are expressed as means AE standard deviation (X AE SD). All statistical analyses were performed using SPSS 18.0 (SPSS, IBM Software Inc., Armonk, NY). An Independent Samples t-Test was used to evaluate the difference in platelet and monocyte counts and growth factor concentrations between groups (WB, PRP, BM, and BMC). A one-way analysis of variance (one-way ANOVA) was used to compare the levels of inflammatory cytokines and histological scores among the groups (Ctrl, NS, PRP, and BMC), and a post hoc Student-Newman-Keuls (SNK)-q test was subsequently used when a significant difference between multiple means was revealed. p < 0.05 was considered statistically significant.
RESULTS

Platelet and Monocyte Concentrations
The concentration of platelets and monocytes in samples of WB, PRP, BM, and BMC are shown in Figure 1 . The concentration of platelets was 2.9-fold higher in Growth Factors Levels TGF-b1 and IGF-1 levels in the samples are displayed in Figure 2 . The level of TGF-b1 was found to be higher in PRP (0.731 ng/ml) than WB (0.223 ng/ml). It was also shown to be higher in BMC (1.462 ng/ml) than BM (0.191 ng/ml), and in BMC than PRP (p < 0.05).
No significant difference was observed in IGF-1 levels between WB and PRP (p > 0.05). However, IGF-1 levels in BMC (110.3 ng/ml) were 3.6-fold and 3.1-fold greater than BM (30.28 ng/ml) and PRP (35.14 ng/ml), respectively (p < 0.05).
Cytokines Concentrations
The concentrations of IL-1b, IL-6, TNF-a, and PGE2 in synovial fluid are shown in Figure 3 . In the PRPtreated group, the levels of IL-6 and PGE2 were demonstrated to be lower than in the NS-treated group (p < 0.05). In the BMC-treated group, the levels of IL-1b, IL-6, TNF-a, and PGE2 were decreased compared with the NS group (p < 0.05), and the concentration of IL-1b was found to be lower in the BMC than PRP group (p < 0.05).
Gross Morphological Observations
A normal knee joint showing no signs of OA was characterized by smooth edges and an intact articular surface in bilateral femoral condyles and tibial plateaus ( Fig. 4A and E) . In the NS group, obvious extensive and full-thickness cartilage defects combined with marked osteophyte development was demonstrated in the medial femoral condyle and tibial plateau (Fig. 4B and F) . Compared with the NS group, the joints treated with PRP revealed a similar area of cartilage damage, but with reduced depth, and moderate osteophyte development ( Fig. 4C and  G) . Although degeneration of the articular surface was also observed in the BMC group, only focal and superficial cartilage erosion and mild osteophyte development was seen compared to the NS and PRP groups ( Fig. 4D and H) .
According to the OARSI macroscopic scoring method for degenerative cartilage, the highest lesion score was observed in the NS group (13.33 AE 1.033) compared to the other groups (p < 0.05). Scores were significantly reduced in both the PRP (8.500 AE 1.378) and BMC (5.333 AE 1.033) groups compared with the NS group, although they remained higher than the Ctrl group (p < 0.05). In addition, a lower score was obtained in the BMC group compared with the PRP group (p < 0.05) (Fig. 5.) .
Histological Examination and Immunohistochemical Staining
Sections from the Ctrl group revealed a smooth articular surface and intact cartilage structure with abundant ECM and COL-2 (Fig. 6A, E, and H) . In the NS group, almost all cartilage structures were lost, subchondral bone was extensively exposed and only a thin fiber-like tissue covered the tidemark, demonstrating a severe OA phenotype (Fig. 6B, F, and I) . Obvious erosion and decreased ECM content were identified in superficial and middle cartilage layers in the PRP group; however, chondrocyte density and ECM were retained in the deep zone (Fig. 6C, G, and J) . Surprisingly, in the BMC group, degenerative changes and articular cartilage erosion were limited within the superficial layer, and normal chondrocyte density and abundant ECM were preserved in the lower layers (Fig. 6D, H, and K) .
According to the modified Mankin scoring system for microscopic cartilage degeneration, the highest score was observed in the NS group (18.53 AE 2.042) compared to other groups (p < 0.05). Following intraarticular injection of PRP or BMC, the scores were significantly decreased compared with the NS group (10.83 AE 2.041 and 7.242 AE 1.835, respectively), but remained higher than the Ctrl group (1.167 AE 0.7528) (p < 0.05). When comparing the two treatment groups, a lower score was demonstrated for the BMC group than the PRP group (p < 0.05) (Fig. 7) .
DISCUSSION
This presented study revealed the efficacy of PRP and BMC for delaying the progression of articular degeneration in a goat OA model, and the effects seen with BMC were superior to those achieved with PRP.
Despite the fact that intra-articular injection of corticosteroid and viscosupplementation have been used as therapies for OA for decades, these treatments rarely achieve optimal cartilage repair and prevent the progression of the disease. 21 Recently, autologous biomaterials have been the focus of studies, given their promise as alternative treatment strategies for OA. 2 One such autologous biomaterial, PRP, appears to have an important role in healing cartilage defects. 4 Clinical research has confirmed that it can provide symptomatic relief and functional improvement in OA patients. 8, 22 Recently, BMC, another novel biomaterial, has been used in studies of chondral injury 11, 23 and degenerative arthritis. 16, 17 However, because these reports lacked comparable interventions and utilized additional adipose-derived products or PRP, the direct effect of BMC on OA remains controversial. 18 In addition, to our knowledge, no 
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studies have been performed to directly compare the difference between PRP and BMC in the treatment of OA. Therefore, this study was designed to evaluate the effect of intra-articular injection of BMC on a goat OA model, and to compare the effect of BMC with that of PRP.
In our study, two-step centrifugations were performed to obtain PRP and BMC. Cell counts revealed that a higher monocyte concentration was observed in BMC than in PRP and BM, and the platelet concentrations were increased in both PRP and BMC groups after centrifugation, but there was no significant difference in platelet counts between the two groups. This data was similar to that in another report. 24 Bone marrow monocytes (BMMCs), an important component of BMC, consist of BMSCs, HSCs, and progenitor cells. BMSCs have been proposed to be a promising biomaterial for the repair of degenerative cartilage because of their anti-inflammatory, multidifferentiative, proliferative and secretory functions. 10 In 2003, Murphy et al. 10 reported that intra-articular injection of BMSCs stimulated chondral regeneration and retarded progressive cartilage destruction in a sheep OA model. Because of the very low number of BMSCs within samples of BMMCs (0.001-0.01%), 25 in vitro culture and expansion is necessary to obtain suitable amounts for clinical application. However, because of the complexity, contamination risk, and high cost of in vitro procedures, the clinical application of BMSCs has been restricted, especially in developing countries. 11 To acquire more BMSCs and avoid in vitro culture or expansion, bone marrow aspirates have been performed by many researchers. Despite the fact that the number of BMSCs in BMC may still be far less than ideal, the cells extracted directly from bone marrow were considered to retain primary regenerative capacity and to avoid senescence. 26 Furthermore, paracrine mechanisms mediated by MSC that modulate joint homeostasis have been suggested. HSCs have also been proven to differentiate into MSCs under certain conditions, and to facilitate osteogenesis and tissue regeneration through cell-to-cell contact with MSCs. 27, 28 A recent paper revealed that more BMMCs, including BMSCs and HSCs, were observed in BMC than in pre-concentration samples. 18 Additionally, our previous research confirmed the effects of BMMCs on joint degeneration, including the downregulation of pro-inflammatory cytokines in synovial fluid and promotion of cartilage regeneration. 19 In this study, we have demonstrated similar positive effects of BMC on inflammation and cartilage repair, and hence propose that BMMCs within BMC may be responsible for these effects.
In addition to being abundant in BMMCs, BMC is also rich in platelets, which may also play a role in OA prevention. It has been confirmed that platelets have the ability to release many growth factors and antiinflammatory cytokines from the cytoplasmic pool after aggregation. These cytokines, such as TGF-b1, IGF-1, platelet-derived growth factor (PDGF), and interleukin 1 receptor antagonist (IL-1ra), have been shown to contribute significantly to cartilage healing and the inhibition of inflammation. [29] [30] [31] [32] In this current study, higher levels of TGF-b1 was detected in both BMC and PRP; IGF-1 levels were greater in BMC than PRP. Although more growth factors were not examined in this study due to a lack of commercially available ELISA kits, Cassano et al. 24 reported that higher concentrations of PDGF and IL-1ra were detected in BMC compared with PRP. It is therefore possible that growth factors with important roles in cartilage repair may be released from both BMMCs and platelets within BMC preparations.
With our increased understanding, the role of inflammatory factors in the development of OA has been outlined in more detail. It has been reported that factors such as IL-1, IL-6, TNF-a, and PGE2 are not only able to disrupt homeostasis within joints but can also induce chondral catabolism and accelerate the degenerative progression seen in OA. 33 Many medicines and biological therapies, including PRP, are used as treatments in OA due to their anti-inflammatory properties. In our study, reduced levels of inflammatory factors levels were observed in synovial fluid from both PRP and BMC groups, with the levels of IL-1b being lowest in BMC samples. Thus, we considered that the reduced levels of inflammatory cytokines demonstrated in the synovial fluid of PRP and BMC groups might imply that inflammatory reactions could be inhibited and chondral degeneration prevented in injured joints.
Previously, several clinical studies have reported benefits from autologous BMC treatment of OA, including symptomatic relief and functional improvement. 16, 17 However, because of differences in disease severity, the absence of comparable interventions, and the utilization of additional biomaterials, the actual effect of BMC remains unclear. Additionally, although these reports described significant differences in clinical scores, molecular and histological analyses were not performed. In this study, we induced an animal model of OA by performing ACL transection and medial meniscectomy. Six weeks post-operatively, BMC was injected intra-articularly three times at regular intervals. Following this, we observed the levels of inflammatory factors in the synovial fluid and histological changes within treated joints, and confirmed the benefits of autologous BMC in the treatment of OA.
Clinically, many studies have demonstrated that treatment with autologous PRP can be beneficial in OA. 5, 34 However, a comparison of BMC and PRP as treatment strategies has seldom been reported. Todate there is no consistency in the recommended BMC injection frequency for OA; however, three intraarticular injections at 4-weekly intervals has been recommended for PRP. 22, 35 Therefore, for consistency we used the same treatment protocol with BMC in this study. Our results reveal that BMC is superior to PRP in promoting cartilage repair and attenuating the progression of degeneration in a goat OA model. We speculate that these advantages may be a result of higher levels of BMMCs and growth factors in BMC.
However, there are some limitations of this study that should be noted. Firstly, this is an animal experiment with a relatively small sample size and short observation periods. Secondly, radiographic evaluations, including MRI, are thought to be the ideal method for observing cartilage degeneration; however, these examinations were not conducted in our study due to the limited conditions and operational difficulty. Therefore, although this investigation provides promising results for autologous BMC, further clinical studies are required to confirm the functional efficacy and long-term effects of BMC in OA.
CONCLUSION
This presented study revealed that intra-articular injection of BMC inhibited inflammation and prevented progressive cartilage degeneration in a goat OA model, and that to the effects seen with BMC were superior to those achieved with PRP.
